ASHA Learning Pass

Log in and check out the Dashboard to view featured courses.

Filter Courses By
Experience
Instructional Level
Results 1 - 10 of 17
Presenter(s): Derek J Stiles, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Congenital cytomegalovirus (cCMV) infection ranks among the leading causes of hearing loss in children. This on demand webinar (available beginning June 8, 2024) will explore the characteristics of cCMV and how it affects hearing, cognition, and movement as well as strategies for clinical care, advocacy, and public health as it relates to cCMV.
Presenter(s): Rebecca Witmer, LCSW; Kaitlyn Mulray, MS, CCC-SLP; Melissa Ferrello, AuD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: TMPRSS3 is a genetic variant associated with either progressive or congenital bilateral sensorineural hearing loss. Through case studies, this on demand webinar (available beginning June 7, 2024) will address multidisciplinary management spanning from diagnosis of hearing loss to cochlear implantation. The presenters will share relevant education for professionals working with children with hearing loss.
Webinar product cover
Presenter(s): Dylan Chan, MD, PhD; Karen G Munoz, EdD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Early childhood is a critical period for auditory, language, and cognitive development, and early identification of permanent hearing loss provides the opportunity for children to receive appropriate and timely intervention and educational services. When children are identified late, they are at increased risk of permanent speech, language, and educational delays. This on demand webinar (available beginning May 3, 2024) will discuss the prevalence of late-identified hearing loss in young children, opportunities to identify hearing problems, and stakeholder actions needed to support child development.
Presenter(s): A.U. Bankaitis, PhD
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Medical professionals who use hearing aids can face challenges when they need to perform auscultation (listening to sounds from various organs, most often with a stethoscope) as part of their job. While the options may not seem straightforward, audiologists can play a key role in helping these medical professionals find an amplified stethoscope solution. This on demand webinar (available beginning March 21, 2024) will discuss key considerations, potential options, and practical steps for helping medical professionals with hearing loss obtain the best solution.
Presenter(s): Lauren Calandruccio, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This recorded dialog features audiologist Lauren Calandruccio, who discusses evaluating speech perception in patients who are non-native speakers of English and for whom Spanish is their native language.
Credit(s): PDHs: 4.0, ASHA CEUs*: 0.4
Summary: The first article in this SIG 18 activity investigates the applications speech-language pathologists (SLPs) and audiologists used most frequently during the beginning of the COVID-19 pandemic. It also discusses the main obstacles to providing speech, language, and hearing services through telepractice. Through the international distribution of an electronic survey, a total of 1,466 surveys from SLPs and audiologists from 40 countries were used for the analysis. The second article discusses the Auditory Verbal UK's training program for prospective listening and spoken language specialist certified auditory verbal therapists delivered globally via telepractice. The article explores, from a global perspective, audiology and early intervention services and perspectives regarding telepractice. The third article explores parents' and therapists' views of the benefits and challenges of telepractice for early intervention for children who are deaf or hard of hearing during the COVID-19 pandemic. Through survey and analysis, the article probes the views of parents, Listening and Spoken Language Specialist Certified Auditory Verbal Therapists in using telepractice to deliver auditory verbal sessions.
Credit(s): PDHs: 2.5, ASHA CEUs*: 0.25
Summary: In “Coupling Hearing Health With Community-Based Group Therapy for Cognitive Health in Low-Income African American Elders,” Postman et al. describe a community-based group intervention to address disparities experienced by African American elders in the early stages of cognitive–communicative decline. The intervention included partnerships with community health centers, culturally informed activities, and ongoing input from staff and participants. The authors describe the advantages of this community-engaged approach, as well as the benefits of joining hearing and cognition for minimizing access barriers. In “Public Health Frameworks in Audiology Education: Rationale and Model for Implementation,” Warren and Levy review how public health education can advance the field of audiology, particularly through coursework and dual degree programs. The authors also describe two frameworks for public health training in an audiology academic setting and identify the competencies that overlap in audiology and public health, helping to illustrate the relevance of public health education in addressing objectives in hearing health care.
Presenter(s): Rachel K Sievers, AuD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: This webinar explores challenges school professionals face regarding Hearing Assistive Technology (HAT), discusses preferred practices for determining HAT eligibility, and shares practical guides to use in your work setting. The speaker addresses common questions like: "How can I ensure that this HAT is appropriate for this student?" "How can I ensure that the equipment is working each day?" "How can I get buy-in from school partners regarding the equipment's day-to-day use?"
Presenter(s): Gayla L. Poling, PhD, CCC-A
Credit(s): PDHs: 1.0, ASHA CEUs*: 0.1
Summary: Hundreds of medications commonly prescribed for anticancer treatments and some infections are known to cause auditory and/or vestibular dysfunction, known as ototoxicity. This course discusses early detection of ototoxicity through increased awareness, leveraging current tools, and clinical practice approaches for serial monitoring, all of which can provide care teams opportunities to identify adverse effects, modify treatment plans to mitigate hearing loss, and utilize individualized interventions. The speaker discusses strategies for preventing or minimizing cochlear damage to preserve quality of life for patients receiving treatment and to reduce the societal burden of hearing loss.
Presenter(s): Dr. O’neil W. Guthrie, MS, PhD, CCC-A
Credit(s): PDHs: 0.5, ASHA CEUs*: 0.05
Summary: Gene therapy offers the promise to correct inherited forms of hearing loss as well as acquired forms such as noise-induced hearing loss, ototoxicity, and presbycusis. However, there are several barriers that must be overcome before such potential can be realized. This course describes the conceptual framework that governs gene therapy today, reveals how this framework has influenced current progress, and discusses a re-imagining of inner ear gene therapy with the goal of achieving outcomes that are clinically relevant and realistic.
<< < 1 2 >>